Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells
Authors:
Open Access
- 29 September 2009
- journal article
- research article
- Published by Springer Nature in Molecular Cancer
- Vol. 8 (1) , 80
Abstract
Background: Chemoresistance acquisition may influence cancer cell biology. Here, bioinformatics analysis of gene expression data was used to identify chemoresistance-associated changes in neuroblastoma biology.Results: Bioinformatics analysis of gene expression data revealed that expression of angiogenesis-associated genes significantly differs between chemosensitive and chemoresistant neuroblastoma cells. A subsequent systematic analysis of a panel of 14 chemosensitive and chemoresistant neuroblastoma cell lines in vitro and in animal experiments indicated a consistent shift to a more pro-angiogenic phenotype in chemoresistant neuroblastoma cells. The molecular mechanims underlying increased pro-angiogenic activity of neuroblastoma cells are individual and differ between the investigated chemoresistant cell lines. Treatment of animals carrying doxorubicin-resistant neuroblastoma xenografts with doxorubicin, a cytotoxic drug known to exert anti-angiogenic activity, resulted in decreased tumour vessel formation and growth indicating chemoresistance-associated enhanced pro-angiogenic activity to be relevant for tumour progression and to represent a potential therapeutic target.Conclusion: A bioinformatics approach allowed to identify a relevant chemoresistance-associated shift in neuroblastoma cell biology. The chemoresistance-associated enhanced pro-angiogenic activity observed in neuroblastoma cells is relevant for tumour progression and represents a potential therapeutic target.Keywords
This publication has 71 references indexed in Scilit:
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic PropertiesPLOS ONE, 2008
- Chemotherapeutic drugs and human tumor cells cytokine networkInternational Journal of Cancer, 2008
- Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast CancerCancer Research, 2008
- Angiogenesis as a target in neuroblastomaEuropean Journal of Cancer, 2008
- N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastomaOncogene, 2008
- Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast CancerNew England Journal of Medicine, 2007
- Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxolApoptosis, 2007
- Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endotheliumBritish Journal of Cancer, 2007
- PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathwaysNucleic Acids Research, 2006
- Superior therapeutic efficacy of N-l-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drugEuropean Journal of Cancer, 1999